Aligned Genetics Inc Capital Reinvestment Ratio
Aligned Genetics Inc capital reinvestment ratio. Aligned Genetics Inc (238120) has a Capital Reinvestment Ratio of 0.24x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩677.20 Million) in capital expenditures (₩165.20 Million). Check 238120 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aligned Genetics Inc (2019–2024)
Capital reinvestment ratio of Aligned Genetics Inc from 2019 to 2024. This chart tracks Aligned Genetics Inc's Capital Reinvestment Ratio across 6 annual periods. Also explore 238120 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Aligned Genetics Inc Capital Reinvestment Ratio by Year (2019–2024)
Aligned Genetics Inc capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see Aligned Genetics Inc (238120) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩3.07 Billion | ₩340.06 Million | ▼ -64.1% |
| 2023 | 0.31x | ₩2.85 Billion | ₩880.42 Million | ▼ -65.7% |
| 2022 | 0.90x | ₩2.22 Billion | ₩2.00 Billion | ▼ -96.3% |
| 2021 | 24.33x | ₩135.97 Million | ₩3.31 Billion | ▲ +799.8% |
| 2020 | 2.70x | ₩35.67 Million | ₩96.43 Million | ▲ +581.3% |
| 2019 | 0.40x | ₩659.29 Million | ₩261.62 Million | — |